News Quantified

WHWK – whitehawk therapeutics, inc. (US:NASDAQ)

Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

12/30

04:16 pm

whwk

Low

Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Whitehawk Therapeutics (NASDAQ:WHWK) is now covered by analysts at Jones Trading. They set a "buy" rating and a $7.00 price target on the stock.

Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}